ATS 2019 Virtual Final Program

P556 Carotid Vasculitis: A Rare Manifestation of Sarcoidosis/ P.T. Neilan, A.A. Mancuso, D.C. Patel, Gainesville, FL, p.A1556 P557 Sarcoloidosis: A Rare Case of Co-Existent Systemic Sarcoidosis and Amyloidosis/ K. Mealey, A. Ly, N. Shah, A. Khan, N. Ravikumar, Springfield, MA, p.A1557 P558 Secondary Organizing Pneumonia Associated with Miliary Tuberculosis/ K.C. Kim, Daegu City, Korea, Republic of, p.A1558 Facilitator : S.A. Suliman, MD, Louisville, KY P559 Sarcoidosis and IPF: The Egg and the Chicken Phenomenon/ A. Arjuna, P.W. Stevenson, H. Alnumait, A. Shahmohammadi, S. Chandrashekaran, Gainesville, FL, p.A1559 P560 Lung Mass with Bilateral Mediastinal Hypermetabolic Lymphadenopathy in a Chronic Smoker. Is That Lung Cancer?/ A. Ali, G. Diaz-Fuentes, M. Niazi, S.K. Venkatram, Bronx, NY, p.A1560 P561 Sarcoidosis Disguised as Malignancy/ R. Patel, M. Kadri, A. Al-khateeb, S. Bellary, H. Sharma, R.A. Miller, A. Klukowicz, Newark, NJ, p.A1561 P562 Palliative Care Lost in the Complexity of Pulmonary Hypertension/ A.V. Sharma, R. Chopra, O. Schwartz, Washington, DC, p.A1562 P563 A Case of Systemic Sarcoidosis Presenting as Hypercalcemia Induced Pancreatitis/ J. Kaur, A.S. Bath, J.R. Ladwig, Kalamazoo, MI, p.A1563 P564 Lofgren Syndrome Masquerading as Cellulitis/ A. Ul Haq, T. Hussain, S.H. Ijaz, S. Daouk, Oklahoma City, OK, p.A1564 P565 Acute Idiopathic Eosinophilic Pneumonia. Not All Cases Are Alike, A Diagnostic Challenge/ C. Vu, J. Pham, W. Lee, Palm Springs, CA, p.A1565 P566 A Challenging Case of Disseminated Sarcoidosis/ N. Addasi, N. Jagan, A. Nayfeh, Z.S. DePew, D. Moore, Omaha, NE, p.A1566 P567 Sarcoidosis Masqueraded as a Malignancy/ L. Delasos, Farmington, CT, p.A1567 P568 A Pancreatic Mass Presenting as a Rare Case of Pancreatic Sarcoidosis/ D. Rutenberg, K.N. Cao, Tampa, FL, p.A1568 CLINICAL THEMATIC POSTER SESSION A41 COPD: EPIDEMIOLOGY 9:15 a.m. - 4:15 p.m. KBHCCD Area B (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. P133 Atrial and Ventricular Axis in COPD and Sub-Phenotypes: The MESA COPD Study/ C. Liberator, D.A. Bluemke, E.A. Hoffman, S.M. Kawut, J. Lima, E.D. Michos, M.R. Prince, A. Swift, K.E. Watson, R.G. Barr, New York, NY, p.A1569 P134 Comparison of Predictive Properties Among Patient Reported Outcomes in Subjects with Chronic Obstructive Pulmonary Disease: Breathlessness, Respiratory Symptoms and Health Status/ K. Nishimura, M. Kusunose, R. Sanda, A. Narita, T. Oga, Obu, Japan, p.A1570 P135 Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)/ K.F. Rabe, L.M. Fabbri, F.J. Martinez, G.T. Ferguson, E. Bourne, P. Darken, K. DeAngelis, M. Aurivillius, C. Reisner, P. Dorinsky, Grosshansdorf, Germany, p.A1571 P136 Breathing-Swallowing Discoordination Is Associated with Poor Prognosis in Patients with COPD/ S. Sato, S. Nagami, Y. Oku, A. Sato, N. Tanabe, N. Yagi, T. Hirai, S. Muro, Kyoto, Japan, p.A1572 P137 The Clinical Phenotype of COPD Near End-of-life/ M. Koh, A. Yii, C.H. Loh, A.A.T. Taha, J. Koh, A. Tee, Singapore, Singapore, p.A1573 P138 Evaluation of Time-to-Triple Therapy in Patients Diagnosed with COPD Initiating Maintenance Therapy with a Fixed-Dose Combination of LAMA/LABA Versus ICS/LABA Within a Large US Health Insurer Database/ C. Moretz, L.G.S. Bengtson, L. Sharpsten, L. Le, E. Koep, J. Tong, B. Hahn, R.H. Stanford, M.J. Asmus, R. Ray, Research Triangle Park, NC, p.A1574 P139 Evaluation of Time-to-First COPD Exacerbation in Patients Diagnosed with COPD Initiating Maintenance Therapy with Inhaled Fixed-Dose Combinations of LAMA/LABA or ICS/LABA Within a Large US Health Insurer Database/ C. Moretz, L. Sharpsten, L.G.S. Bengtson, E. Koep, L. Le, J. Tong, B. Hahn, R.H. Stanford, M.J. Asmus, R. Ray, Research Triangle Park, NC, p.A1575 P140 Prevalence of IgG Deficiency in Veterans with Chronic Obstructive Pulmonary Disease/ K.D.V. Tovar, R. Rico, G. Urdaneta, I.A. Vital, M. Mirsaeidi, G.E. Holt, R.A. Calderon Candelario, M.A. Campos, Miami, FL, p.A1576 P141 Association of Anemia and Health Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease/ A.G. Dragnich, K. Pike, E.R. Swenson, S.G. Adams, H. Nguyen, V. Fan, Seattle, WA, p.A1577 P142 Determinants of Physical Activity in Patients with COPD: A 3-Month Cohort Study/ A.G. Dragnich, N. Yee, H.Q. Nguyen, I. Gylys-Colwell, E.R. Locke, M. Moy, S. Magzamen, V.S. Fan, Seattle, WA, p.A1578 P143 Factors Associated with 30-Day Readmission in Patients with Chronic Obstructive Pulmonary Disease/ L. Kearney, K. Olenik, F. Little, A. Foreman, C. O’Donnell, C. Wakeman, J. Howard, G. Fix, J. Hicks, M.-L. Drainoni, R.S. Wiener, H. Kathuria, Boston, MA, p.A1579 P144 BAL and Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations, Clinical and CT Phenotypes, an Analysis of SPIROMICS/ N. Putcha, M.T. Dransfield, D. LaFon, J. Woo, A. Azar, A. Fawzy, C.B. Cooper, R.P. Bowler, A.P. Comellas, J.A. Krishnan, M.K. Han, D. Couper, S.P. Peters, M.B. Drummond, W.K. O’Neal, G.J. Criner, F.J. Martinez, J.L. Curtis, R.G. Barr, P. Woodruff, N.N. Hansel, Baltimore, MD, p.A1580 ATS 2019 • Dallas, TX SUNDAY • MAY 19 57 SUNDAY MORNING